OCA at 14:38, 18 October 2023

2023-10-18T14:38:45Z

←Older revision		Revision as of 14:38, 18 October 2023
Line 1:		Line 1:

-	====	+	==CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-41 A.K.A 7-[1-phenyl-3-({4-phenylbicyclo[2.2.2]octan-1-yl}amino)propyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine==
-	<StructureSection load='6wy7' size='340' side='right'caption='[[6wy7]]' scene=''>	+	<StructureSection load='6wy7' size='340' side='right'caption='[[6wy7]], [[Resolution\|resolution]] 2.09Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6wy7]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WY7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6WY7 FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6wy7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wy7 OCA], [~~http~~://pdbe.org/6wy7 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6wy7 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6wy7 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6wy7 ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.089Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=HEC:HEME+C'>HEC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=UFD:7-{(1R)-1-phenyl-3-[(4-phenylbicyclo[2.2.2]octan-1-yl)amino]propyl}-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine'>UFD</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6wy7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wy7 OCA], [https://pdbe.org/6wy7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6wy7 RCSB], [https://www.ebi.ac.uk/pdbsum/6wy7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6wy7 ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/PERM_HUMAN PERM_HUMAN] Defects in MPO are the cause of myeloperoxidase deficiency (MPOD) [MIM:[https://omim.org/entry/254600 254600]. A disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis.<ref>PMID:8142659</ref> <ref>PMID:7904599</ref> <ref>PMID:8621627</ref> <ref>PMID:9637725</ref> <ref>PMID:9354683</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/PERM_HUMAN PERM_HUMAN] Part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In the stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Myeloperoxidase (MPO) is a heme peroxidase found in neutrophils, monocytes and macrophages that efficiently catalyzes the oxidation of endogenous chloride into hypochlorous acid for antimicrobial activity. Chronic MPO activation can lead to indiscriminate protein modification causing tissue damage, and has been associated with chronic inflammatory diseases, atherosclerosis, and acute cardiovascular events. Triazolopyrimidine 5 is a reversible MPO inhibitor; however it suffers from poor stability in acid, and is an irreversible inhibitor of the DNA repair protein methyl guanine methyl transferase (MGMT). Structure-based drug design was employed to discover benzyl triazolopyridines with improved MPO potency, as well as acid stability, no reactivity with MGMT, and selectivity against thyroid peroxidase (TPO). Structure-activity relationships, a crystal structure of the MPO-inhibitor complex, and acute in vivo pharmacodynamic data are described herein.
		+
		+	Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase.,Shaw SA, Vokits BP, Dilger AK, Viet A, Clark CG, Abell LM, Locke GA, Duke G, Kopcho LM, Dongre A, Gao J, Krishnakumar A, Jusuf S, Khan J, Spronk SA, Basso MD, Zhao L, Cantor GH, Onorato JM, Wexler RR, Duclos F, Kick EK Bioorg Med Chem. 2020 Sep 1;28(22):115723. doi: 10.1016/j.bmc.2020.115723. PMID:33007547<ref>PMID:33007547</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6wy7" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Myeloperoxidase\|Myeloperoxidase]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Z-disk~~]]	+	[[Category: Khan JA]]

OCA at 05:48, 14 October 2020

2020-10-14T05:48:24Z

←Older revision		Revision as of 05:48, 14 October 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6wy7 ~~is ON HOLD until Paper Publication~~	+	====
-		+	<StructureSection load='6wy7' size='340' side='right'caption='[[6wy7]]' scene=''>
-	~~Authors~~: ~~Khan, J~~.A.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description: CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound~~-~~41 A~~.K.~~A 7-~~[~~1-phenyl-3-({4-phenylbicyclo[2~~.2.2]~~octan~~-~~1-yl}amino)propyl~~]~~-3H-~~[1,~~2,3~~]~~triazolo~~[4,5-b]~~pyridin-5-amine~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6wy7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wy7 OCA], [http://pdbe.org/6wy7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6wy7 RCSB], [http://www.ebi.ac.uk/pdbsum/6wy7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6wy7 ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	</table>
-	[[Category: ~~Khan, J.A~~]]	+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Z-disk]]

OCA at 08:35, 17 June 2020

2020-06-17T08:35:18Z

←Older revision		Revision as of 08:35, 17 June 2020
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6wy7 is ON HOLD	+	The entry 6wy7 is ON HOLD until Paper Publication

	Authors: Khan, J.A.		Authors: Khan, J.A.

OCA: Protected "6wy7" [edit=sysop:move=sysop]

2020-05-20T04:21:13Z

Protected "6wy7" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:21, 20 May 2020

OCA: New page: '''Unreleased structure''' The entry 6wy7 is ON HOLD Authors: Khan, J.A. Description: CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-41 A.K.A 7-[1-phenyl-3-...

2020-05-20T04:21:12Z

New page: '''Unreleased structure''' The entry 6wy7 is ON HOLD Authors: Khan, J.A. Description: CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-41 A.K.A 7-[1-phenyl-3-...

New page

'''Unreleased structure'''

The entry 6wy7 is ON HOLD

Authors: Khan, J.A.

Description: CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-41 A.K.A 7-[1-phenyl-3-({4-phenylbicyclo[2.2.2]octan-1-yl}amino)propyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine
[[Category: Unreleased Structures]]
[[Category: Khan, J.A]]

6wy7 - Revision history

OCA at 14:38, 18 October 2023

OCA at 05:48, 14 October 2020

OCA at 08:35, 17 June 2020

OCA: Protected "6wy7" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 6wy7 is ON HOLD Authors: Khan, J.A. Description: CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-41 A.K.A 7-[1-phenyl-3-...